Integra LifeSciences IART Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's interest expense?
- Integra LifeSciences (IART) reported interest expense of $22.47M in Q1 2026.
- How has Integra LifeSciences's interest expense changed year-over-year?
- Integra LifeSciences's interest expense increased by 19.4% year-over-year, from $18.82M to $22.47M.
- What is the long-term trend for Integra LifeSciences's interest expense?
- Over 4 years (2021 to 2025), Integra LifeSciences's interest expense has grown at a 14.4% compound annual growth rate (CAGR), from $50.4M to $86.26M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.